2.89 quarters of cash seems to be adequate to get us through to option exercise period of May 2024 without need for a CR if SP moves on assay results and Shareholders start converting 1st calendar Qtr 2024 in anticipation, we will raise circa $12m. JB a safe pair of hands IMO.
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $6.995M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $2.609K | 325.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 542511 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1733448 | 3 |
View Market Depth
| Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
| RR1 (ASX) Chart |